Harmony Biosciences Holdings, Inc. Stock, NASDAQ:HRMY
630 West Germantown Pike, Suite 215, Plymouth Meeting, Pennsylvania 19462
United States of America
Number of Employees:
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.